Andrew Haynes, MD
andrewhaynes.bsky.social
Andrew Haynes, MD
@andrewhaynes.bsky.social
Pediatric Infectious Disease at Children’s Colorado. Interested in oral antibiotics and pharmacometrics.
And it’s unpredictable. Sometimes just colonizing flora you should ignore and doesn’t do anything. Other times tries to kill you in 12 hours.
November 20, 2024 at 4:27 AM
Welcome to Bluesky!
November 13, 2024 at 4:21 AM
As long as it's an oral regimen, I'll let it slide. Get the PICC lines out!
November 12, 2024 at 4:57 PM
I was summoned by talk of cefdinir… @mikerusso.bsky.social
November 12, 2024 at 4:42 PM
Interestingly, in our cephalexin PK paper, QID with spacing like that had similar if not better PTAs than q6. So very much agree with that kind of QID dosing, if you’re going to give 4 times a day. Or just TID. I do a mix of both.
November 12, 2024 at 4:41 PM
Here!
November 12, 2024 at 4:37 PM
Amox is still used way more. Personally, I think the high spontaneous resolution rate of respiratory viral syndromes reinforces the belief that cefdinir works. And it probably works fine for penicillin susceptible S pneumo, which is a lot of what’s out there.
November 12, 2024 at 4:33 PM